Emerging Vaccine-Breakthrough SARS-CoV‑2 Variants
journal contributionposted on 2022-02-08, 21:44 authored by Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
The surge of COVID-19 infections has been fueled by new SARS-CoV-2 variants, namely Alpha, Beta, Gamma, Delta, and so forth. The molecular mechanism underlying such surge is elusive due to the existence of 28 554 unique mutations, including 4 653 non-degenerate mutations on the spike protein. Understanding the molecular mechanism of SARS-CoV-2 transmission and evolution is a prerequisite to foresee the trend of emerging vaccine-breakthrough variants and the design of mutation-proof vaccines and monoclonal antibodies. We integrate the genotyping of 1 489 884 SARS-CoV-2 genomes, a library of 130 human antibodies, tens of thousands of mutational data, topological data analysis, and deep learning to reveal SARS-CoV-2 evolution mechanism and forecast emerging vaccine-breakthrough variants. We show that prevailing variants can be quantitatively explained by infectivity-strengthening and vaccine-escape (co-)mutations on the spike protein RBD due to natural selection and/or vaccination-induced evolutionary pressure. We illustrate that infectivity strengthening mutations were the main mechanism for viral evolution, while vaccine-escape mutations become a dominating viral evolutionary mechanism among highly vaccinated populations. We demonstrate that Lambda is as infectious as Delta but is more vaccine-resistant. We analyze emerging vaccine-breakthrough comutations in highly vaccinated countries, including the United Kingdom, the United States, Denmark, and so forth. Finally, we identify sets of comutations that have a high likelihood of massive growth: [A411S, L452R, T478K], [L452R, T478K, N501Y], [V401L, L452R, T478K], [K417N, L452R, T478K], [L452R, T478K, E484K, N501Y], and [P384L, K417N, E484K, N501Y]. We predict they can escape existing vaccines. We foresee an urgent need to develop new virus combating strategies.
induced evolutionary pressurehighly vaccinated countriesco -) mutationstopological data analysis130 human antibodiesescape mutations becomemolecular mechanism underlyingforecast emerging vaccineanalyze emerging vaccineescape existing vaccinesinfectivity strengthening mutations2 evolution mechanismmolecular mechanismemerging vaccinedegenerate mutationsproof vaccinesmutational datamonoclonal antibodiesmain mechanism2 variants2 transmission2 genomesviral evolutionurgent needunited statesunited kingdomspike proteinquantitatively explainedprevailing variantsnatural selectionnamely alphan501y ].n501y ],massive growthidentify setshigh likelihoodelusive duedeep learningbreakthrough variants19 infections